Prentiss Smith & Co’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-7
Closed -$1K 349
2015
Q3
$1K Hold
7
﹤0.01% 317
2015
Q2
$3K Hold
7
﹤0.01% 263
2015
Q1
$3K Hold
7
﹤0.01% 283
2014
Q4
$2K Hold
7
﹤0.01% 299
2014
Q3
$1K Hold
7
﹤0.01% 235
2014
Q2
$2K Hold
7
﹤0.01% 228
2014
Q1
$2K Hold
7
﹤0.01% 239
2013
Q4
$2K Hold
7
﹤0.01% 235
2013
Q3
$4K Hold
7
﹤0.01% 211
2013
Q2
$2K Buy
+7
New +$2K ﹤0.01% 242